Veeva Systems to Host 2025 R&D and Quality Summit for Biopharmaceutical Innovation
- Veeva Systems will host the R&D and Quality Summit in Boston on September 3-4, 2025, attracting over 2,000 participants.
- The summit will showcase Veeva AI innovations, enhancing data access and operational efficiency for life sciences organizations.
- Veeva aims to foster collaboration and share best practices among industry leaders to accelerate the delivery of innovative therapies.
Veeva Systems to Host Pioneering R&D and Quality Summit in 2025
Veeva Systems is preparing to host the Veeva R&D and Quality Summit on September 3-4, 2025, in Boston, where leaders from prominent biopharmaceutical companies will converge to share innovative strategies in the life sciences sector. With an expected attendance of over 2,000 participants from companies including Merck, Pfizer, and Intercept Pharmaceuticals, the summit aims to foster collaboration on critical areas such as clinical, regulatory, safety, and quality management. This event underscores Veeva’s pivotal role in shaping the future of the biopharmaceutical landscape, particularly through its advanced software solutions.
The summit will serve as a platform for Veeva to showcase its latest innovations, particularly the Veeva AI integrated into its Vault Platform. This technology enables secure access to crucial data and workflows, enhancing operational efficiency for life sciences organizations. Attendees will gain insights into the capabilities of Veeva AI, including the creation of custom agents tailored to their unique needs. By facilitating knowledge exchange, the summit positions Veeva as a leader in driving technological advancements that support the rapid delivery of medicines to patients.
An extensive agenda featuring over 100 sessions will highlight transformative practices within the industry. Notable discussions will include Merck's unified operations for clinical data management and FUJIFILM Biotechnologies' transition to a global quality management system. Additionally, Immunovant will elaborate on enhancing study oversight in outsourced trials through real-time access to CRO data, while Sanofi will present streamlined training solutions for study teams. Jim Reilly, president of Veeva Development Cloud, emphasizes the summit's role in accelerating the delivery of innovative therapies by fostering a collaborative environment where industry professionals can share their experiences and best practices.
In addition to the summit, Veeva continues to strengthen its commitment to innovation in cloud software for life sciences. The event serves as a testament to the company's dedication to advancing industry standards and improving the efficiency of clinical development processes. By bringing together diverse stakeholders, Veeva aims to facilitate a comprehensive dialogue on the future of research and development in biopharmaceuticals.
As the summit approaches, interested participants can find more information and register at veeva.com/Summit, highlighting Veeva’s ongoing efforts to lead the way in enhancing operational excellence within the life sciences ecosystem.